A Common Polymorphism Renders the Luteinizing Hormone Receptor Protein More Active by Improving Signal Peptide Function and Predicts Adverse Outcome in Breast Cancer Patients
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.